Communication of personalised disease risk by general practitioners to motivate smoking cessation in England: a cost‐effectiveness and research prioritisation study.

Background and Aims: Communication of personalised disease risk can motivate smoking cessation. We assessed whether routine implementation of this intervention by general practitioners (GPs) in England is cost‐effective or whether we need further research to better establish its effectiveness. Desig...

Descripción completa

Detalles Bibliográficos
Publicado en:Addiction Vol. 117; no. 5; pp. 1438 - 1450
Autores principales: Adamson, Alexander, Portas, Laura, Accordini, Simone, Marcon, Alessandro, Jarvis, Deborah, Baio, Gianluca, Minelli, Cosetta
Formato: research tables/charts Journal Article
Publicado: Wiley-Blackwell May2022
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=156112704&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 156112704
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        09652140
        AIO
      jtl: Addiction
      issn: 09652140
      maglogo: Y
    pubinfo:
      dt: May2022
      vid: 117
      iid: 5
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        156112704
        154732164
        156112704
        156112704
        10.1111/add.15773
        156112704
      ppf: 1438
      ppct: 12
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: C
          – @attributes:
              type: P
      tig:
        atl: Communication of personalised disease risk by general practitioners to motivate smoking cessation in England: a cost‐effectiveness and research prioritisation study.
      aug:
        au:
          Adamson, Alexander
          Portas, Laura
          Accordini, Simone
          Marcon, Alessandro
          Jarvis, Deborah
          Baio, Gianluca
          Minelli, Cosetta
        affil: National Heart & Lung Institute, Imperial College London, London, UK
      sug:
        subj:
          Physicians, Family Psychosocial Factors
          Communication Methods
          Disease Risk Factors
          Risk Assessment
          Smoking Cessation
          Motivation
          Human
          Cost Benefit Analysis
          Research, Medical
          Research Priorities
          Adult
          Middle Age
          Quality-Adjusted Life Years
          Smoking Mortality
          Pulmonary Disease, Chronic Obstructive
          Lung Neoplasms
          Stroke
          Disease Economics
          Uncertainty
          Odds Ratio
          Credibility (Research)
          Sex Factors
          Age Factors
          England
          Adult: 19-44 years
          Middle Aged: 45-64 years
      ab: Background and Aims: Communication of personalised disease risk can motivate smoking cessation. We assessed whether routine implementation of this intervention by general practitioners (GPs) in England is cost‐effective or whether we need further research to better establish its effectiveness. Design Cost‐effectiveness analysis (CEA) with value of information (VoI) analysis from the UK National Health Service perspective, using GP communication of personalised disease risk on smoking cessation versus usual care. Setting: GP practices in England. Study population: Healthy smokers aged 35–60 years attending the GP practice. Measurements Effectiveness of GP communication of personalised disease risk on smoking cessation was estimated through systematic review and meta‐analysis. A Bayesian CEA was then performed using a lifetime Markov model on smokers aged 35–60 years that measured lifetime costs and quality‐adjusted life‐years (QALYs) assigned to the four diseases contributing the most to smoking‐related morbidity, mortality and costs: chronic obstructive pulmonary disease, lung cancer, myocardial infarction and stroke. Costs and QALYs for each disease state were obtained from the literature. VoI analysis identified sources of uncertainty in the CEA and assessed how much would be worth investing in further research to reduce this uncertainty. Findings The meta‐analysis odds ratio for the effectiveness estimate of GP communication of personalised disease risk was 1.48 (95% credibility interval, 0.91–2.26), an absolute increase in smoking cessation rates of 3.84%. The probability of cost‐effectiveness ranged 89–94% depending on sex and age. VoI analysis indicated that: (i) uncertainty in the effectiveness of the intervention was the driver of the overall uncertainty in the CEA; and (ii) a research investment to reduce this uncertainty is justified if lower than £27.6 million (£7 per smoker). Conclusions: Evidence to date shows that, in England, incorporating disease risk communication into general practitioners' practices to motivate smoking cessation is likely to be cost‐effective compared with usual care.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N